Exchange: NASDAQ·Updated 04:10 PM EST

DYAI Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 12

Estimated EPS

-$0.05

Reported EPS

-$0.04

Surprise

+11.11%

Estimated Rev

$1.43M

Reported Rev

$0.45M

Surprise

-68.67%

Dyadic expects to receive the $225,000 milestone payment and recognize it as revenue in the fourth quarter of 2026, following the first commercial sale of its second chymosin product.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.04
--
--
N/A
Q3 '26
-$0.05
-$0.04
11.11%
BEAT
Q2 '26
-$0.04
-$0.06
-71.43%
MISSED
Q1 '26
-$0.04
-$0.05
-25.00%
MISSED
Q4 '25
-$0.05
-$0.04
11.11%
BEAT

Advertisement|Remove ads.